• Dixon Technologies (India) Limited stock is up 4% at $12756.00 as an inter-ministerial panel signals imminent approval for its joint venture with Vivo.
  • The long-pending deal, signed in December 2024, will see Dixon hold a majority 51% stake, significantly reducing Vivo's risk exposure in India and boosting Dixon's electronics manufacturing capabilities.
  • JPMorgan has reiterated its "overweight" rating on DIXON.NS, identifying it as a top pick in the EMS sector with a target price of Rs 12,700, anticipating substantial upside from the JV's approval.